VORSCHAU

PRESSETERMINE

AKTUELLES PRESSEFOTO



WETTER
Graz: bedeckt
24°
Innsbruck: Regen
22°
Linz: Regen
22°
Wien: bedeckt
20°
© wetter.net

Stadtname / PLZ

AKTIENKURSE
 
ADHOC
Di, 30.03.2021 23:10
Meldung drucken Artikel weiterleiten
pta20210330041
Public disclosure of inside information according to article 17 MAR
Pressefach Pressefach

capsensixx AG: Preliminary results for 2020 exceed earnings forecast

Frankfurt am Main (pta041/30.03.2021/23:10) - Preliminary results for 2020 exceed earnings forecast

* Earnings after taxes (without non controlling interests) 2020: EUR 2.3 million (2019: 2.4 million)
* DVFA epS per share 2020: EUR 0.66 (2019: EUR 0.70)
Frankfurt am Main, March 30, 2021
According to preliminary figures, capsensixx closed the 2020 financial year - which was characterized by high uncertainties due to COVID-19 - with a result for 2020 that was above the annual forecast.
The following key figures for 2019 and 2020 are given before deduction of third-party shares, unless otherwise indicated.
In 2020, net commission income increased by 4.2% to EUR 24.2 million (2019: EUR 23.2 million).
The result after taxes (without non controlling interests) is reported at EUR 2.3 million (2019: EUR 2.4 million) in the 2020 financial year. The DVFA eps are reported at EUR 0.66 (2019: EUR 0.70).
With these preliminary results for the 2020 financial year, the forecast for the 2020 financial year made in the first half of 2020 was exceeded. The positive earnings trend continued in the second half of 2020. The good start to the year 2021 signals that - despite the unchanged uncertainties caused by COVID-19 - this earnings trend should continue for the financial year 2021.
The share buyback program that has started is to be continued in the further course of the financial year.
The annual report 2020 of capsensixx - as published in the financial calendar - will be available from April 27, 2020 at www.capsensixx.de.

(Ende)

Aussender: capsensixx AG
Bettinastraße 57-59
60325 Frankfurt am Main
Deutschland
Ansprechpartner: Martin Stuerner
Tel.: +49 69 7680585-25
E-Mail:
Website: www.capsensixx.de
ISIN(s): DE000A2G9M17 (share)
Börsen: regulated market in Frankfurt; free market in Dusseldorf, free market in Munich, free market in Stuttgart; open market in Berlin, Tradegate
capsensixx AG
   
Wie fanden Sie diese Meldung?
Weitersagen
likes dislike Share Share |
Social Media
ETARGET

FOCUSTHEMA


SPECIALS


Werbung
middleAdvertising